These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 1355747

  • 21. High frequency of the HLA-DRB1*0405-(Dw15)-DQw8 haplotype in Spaniards and its relationship to diabetes susceptibility.
    Morales P, Martinez-Laso J, Martin-Villa JM, Corell A, Vicario JL, Varela P, Pérez-Aciego P, Arnaiz-Villena A.
    Hum Immunol; 1991 Nov; 32(3):170-5. PubMed ID: 1774197
    [Abstract] [Full Text] [Related]

  • 22. Trans-racial studies implicate HLA-DQ as a component of genetic susceptibility to type 1 (insulin-dependent) diabetes.
    Fletcher J, Mijovic C, Odugbesan O, Jenkins D, Bradwell AR, Barnett AH.
    Diabetologia; 1988 Dec; 31(12):864-70. PubMed ID: 2907318
    [Abstract] [Full Text] [Related]

  • 23. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children.
    Sugihara S, Sakamaki T, Konda S, Murata A, Wataki K, Kobayashi Y, Minamitani K, Miyamoto S, Sasaki N, Niimi H.
    Diabetes; 1997 Nov; 46(11):1893-7. PubMed ID: 9356042
    [Abstract] [Full Text] [Related]

  • 24. T cell defined HLA epitopes and T cell receptor polymorphism in insulin dependent diabetes mellitus.
    Sheehy MJ.
    Baillieres Clin Endocrinol Metab; 1991 Jun; 5(2):341-55. PubMed ID: 1716435
    [Abstract] [Full Text] [Related]

  • 25. Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes.
    Mangklabruks A, Cox N, DeGroot LJ.
    J Clin Endocrinol Metab; 1991 Aug; 73(2):236-44. PubMed ID: 1677360
    [Abstract] [Full Text] [Related]

  • 26. HLA-DP variation as additional risk factor in IDDM.
    Easteal S, Kohonen-Corish MR, Zimmet P, Serjeantson SW.
    Diabetes; 1990 Jul; 39(7):855-7. PubMed ID: 1972363
    [Abstract] [Full Text] [Related]

  • 27. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.
    Fennessy M, Metcalfe K, Hitman GA, Niven M, Biro PA, Tuomilehto J, Tuomilehto-Wolf E.
    Diabetologia; 1994 Sep; 37(9):937-44. PubMed ID: 7806025
    [Abstract] [Full Text] [Related]

  • 28. HLA-DR and -DQ DNA genotyping in insulin-dependent diabetes patients in South India.
    Serjeantson SW, Ranford PR, Kirk RL, Kohonen-Corish MR, Mohan V, Ramachandran A, Snehalatha C, Viswanathan M.
    Dis Markers; 1987 Jun; 5(2):101-8. PubMed ID: 2901931
    [Abstract] [Full Text] [Related]

  • 29. HLA-DQA1 and DQB1 alleles in French and Algerian type 1 diabetic subjects.
    Gu XF, Larger E, Clauser E, Bessaoud K, Krishnamoorthy R, Elion J, Assan R.
    Diabetes Res; 1991 Aug; 17(4):189-97. PubMed ID: 1688068
    [Abstract] [Full Text] [Related]

  • 30. Transracial evidence for the influence of the homologous HLA DR-DQ haplotype on transmission of HLA DR4 haplotypes to diabetic children.
    Park YS, She JX, Noble JA, Erlich HA, Eisenbarth GS.
    Tissue Antigens; 2001 Mar; 57(3):185-91. PubMed ID: 11285125
    [Abstract] [Full Text] [Related]

  • 31. HLA-DR, DQ and anti-GAD antibodies in first degree relatives of type I diabetes mellitus.
    Serrano-Ríos M, Gutierrez-López MD, Pérez-Bravo F, Martínez MT, Antona J, Rowley M, Mackay I, Zimmet P.
    Diabetes Res Clin Pract; 1996 Oct; 34 Suppl():S133-9. PubMed ID: 9015682
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. HLA-DQ beta-chain restriction fragment length polymorphism as a risk marker in type 1 (insulin-dependent) diabetes mellitus: a Finnish family study.
    Reijonen H, Ilonen J, Knip M, Michelsen B, Akerblom HK.
    Diabetologia; 1990 Jun; 33(6):357-62. PubMed ID: 1974216
    [Abstract] [Full Text] [Related]

  • 34. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
    Urcelay E, Santiago JL, de la Calle H, Martínez A, Méndez J, Ibarra JM, Maluenda C, Fernández-Arquero M, de la Concha EG.
    BMC Genomics; 2005 Apr 20; 6():56. PubMed ID: 15842729
    [Abstract] [Full Text] [Related]

  • 35. Heterogeneity of HLA genetic factors in IDDM susceptibility.
    Martell M, Marcadet A, Moine A, Boitard C, Deschamps I, Dausset J, Bach JF, Cohen D.
    Immunogenetics; 1990 Apr 20; 31(4):233-40. PubMed ID: 1970333
    [Abstract] [Full Text] [Related]

  • 36. Association of particular HLA class II alleles, haplotypes and genotypes with susceptibility to IDDM in the Belgian population.
    Buyse I, Sandkuyl LA, Zamani Ghabanbasani M, Gu XX, Bouillon R, Bex M, Dooms L, Emonds MP, Duhamel M, Marynen P.
    Diabetologia; 1994 Aug 20; 37(8):808-17. PubMed ID: 7988783
    [Abstract] [Full Text] [Related]

  • 37. Restriction fragment length polymorphism of HLA and non-HLA genes in DR3/4 heterozygous Danish insulin-dependent diabetic patients and healthy individuals: reassessment of the influence of alpha DX and insulin-linked polymorphic loci, and new splits of DQw3 haplotypes.
    Zerbib A, Mølvig J, Thomsen M, Coppin H, Cambon-Thomsen A, Sommer E, Nerup J, De Preval C.
    Dis Markers; 1989 Aug 20; 7(1):27-41. PubMed ID: 2565778
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. HLA class II (DR, DQ) in Japanese patients with type 1 diabetes mellitus.
    Tanaka M, Abe J, Ito J, Horikawa R, Miki Y, Nakayama M, Kohsaka T, Tanae A, Hibi I.
    Acta Paediatr Jpn; 1990 Dec 20; 32(6):645-50. PubMed ID: 1982037
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.